ID
39612
Descripción
Study ID: 110852 Clinical Study ID: 110852 Study Title: MD7110852, A Phase 2b Dose-Ranging Study of Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections for the Treatment of Neovascular Age-Related Macular Degeneration Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01134055 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: pazopanib eye drops, ranibizumab intravitreal injection, placebo Trade Name: pazopanib, ranibizumab Study Indication: Macular Degeneration
Palabras clave
Versiones (1)
- 3/2/20 3/2/20 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
3 de febrero de 2020
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections for the Treatment of Neovascular Age-Related Macular Degeneration NCT01134055
Screen - Re-Screening data; Study Eye; Ranibizumab Injection
- StudyEvent: ODM
Descripción
Study Eye
Alias
- UMLS CUI-1
- C0008972
- UMLS CUI-2
- C0015392
Descripción
Ranibizumab Injection
Alias
- UMLS CUI-1
- C1566537
- UMLS CUI-2
- C1272883
Similar models
Screen - Re-Screening data; Study Eye; Ranibizumab Injection
- StudyEvent: ODM
C2347804 (UMLS CUI [1,2])
C2347804 (UMLS CUI [1,2])
C2348585 (UMLS CUI [2])
C0015392 (UMLS CUI [1,2])
C0205396 (UMLS CUI [1,3])
C1272883 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
C0008972 (UMLS CUI [2,1])
C0015392 (UMLS CUI [2,2])